Skip to content

Clinical trials

Dyslipidemias trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Country / region: United Kingdom Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20043
20055
20067
20072
20082
20091
20102
20111
20121
20131
20142
20153
20161
20173
20181
20203
20222
20234
20244
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Recruiting4
Terminated3
Not yet recruiting2
Active, not recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kowa Research Europe7
Takeda7
Amgen3
AstraZeneca3
Novartis Pharmaceuticals3
Xention Ltd3
Kastle Therapeutics, LLC2
Liverpool John Moores University2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias54
Hypercholesterolemia21
Cardiovascular Diseases10
Diabetes Mellitus, Type 210
Hyperlipidemias10
Lipid Metabolism Disorders7
Atherosclerosis6
Diabetes Mellitus6
Glucose Metabolism Disorders6
Metabolic Diseases6

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.